Gut dysbiosis in Parkinson’s disease: A systematic review of human studies
Eurasian Journal of Medicine and Oncology · 23.04.2026 · 10 (2) · 025510527
DOI: 10.36922/ejmo025510527 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Eurasian Journal of Medicine and Oncology, online erschienen am 23.04.2026. Verfasst von Arberesha Bexheti-Ferati und 14 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Parkinson’s disease (PD) is increasingly correlated to gastrointestinal disturbances and intestinal microbiota alterations. Growing evidence suggests that shifts in gut microbial communities may influence immune activation and metabolic pathways relevant to PD.
Objective
This systematic review examines microbial changes in PD and their clinical relevance.
Methods
A systematic search of PubMed, Scopus, and Web of Science identified 819 records. After removing duplicates and screening, 521 full-text articles were evaluated. Ten studies met the inclusion criteria, focusing on human subjects and original data on gut microbiota composition, function, or modulation in PD.
Results
The microbiome profile most frequently reported in PD includes a drop in overall diversity and in bacterial taxa associated with short-chain fatty acid production, alongside a shift toward taxa commonly associated with inflammatory states (e.g., Enterobacteriaceae). Most studies reported associations between dysbiosis and motor severity, constipation, autonomic dysfunction, and neuropsychiatric symptoms. Interventions such as resistant starch supplementation and acupuncture improved microbial profiles and some clinical outcomes. Machine-learning approaches showed promising diagnostic potential based on microbial signatures.
Conclusions
Gut dysbiosis is significantly associated with PD clinical features. Although early evidence suggests potential therapeutic and diagnostic applications, methodological heterogeneity and small sample sizes highlight the need for standardized, longitudinal research.
Zitieren
APA
Bexheti-Ferati, A., Ferati, K., Inchingolo, A. D., Marinelli, G., Bassi, P., Lagioia, R., Rizzo, A., Inchingolo, F., Vinjolli, F., Palermo, A., Bordea, I. R., Maspero, C., Minervini, G., Inchingolo, A. M., & Dipalma, G. (2026). Gut dysbiosis in Parkinson’s disease: A systematic review of human studies. Eurasian Journal of Medicine and Oncology, 10(2), 025510527. https://doi.org/10.36922/ejmo025510527
Vancouver
Bexheti-Ferati A, Ferati K, Inchingolo AD, Marinelli G, Bassi P, Lagioia R, et al. Gut dysbiosis in Parkinson’s disease: A systematic review of human studies. Eurasian Journal of Medicine and Oncology. 2026;10(2):025510527. doi:10.36922/ejmo025510527
BibTeX
@article{BexhetiFerati2026,
author = {Bexheti-Ferati, Arberesha and Ferati, Kenan and Inchingolo, Alessio Danilo and Marinelli, Grazia and Bassi, Paola and Lagioia, Rosalba and Rizzo, Antonio and Inchingolo, Francesco and Vinjolli, Franceska and Palermo, Andrea and Bordea, Ioana Roxana and Maspero, Cinzia and Minervini, Giuseppe and Inchingolo, Angelo Michele and Dipalma, Gianna},
title = {Gut dysbiosis in Parkinson’s disease: A systematic review of human studies},
journal = {Eurasian Journal of Medicine and Oncology},
year = {2026},
volume = {10},
number = {2},
pages = {025510527},
doi = {10.36922/ejmo025510527}
}
EUVIMED